These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 12270182)

  • 1. Cytotoxic acridinylthiourea and its platinum conjugate produce enzyme-mediated DNA strand breaks.
    Brow JM; Pleatman CR; Bierbach U
    Bioorg Med Chem Lett; 2002 Oct; 12(20):2953-5. PubMed ID: 12270182
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of the diamine nonleaving group in platinum-acridinylthiourea conjugates on DNA damage and cytotoxicity.
    Guddneppanavar R; Choudhury JR; Kheradi AR; Steen BD; Saluta G; Kucera GL; Day CS; Bierbach U
    J Med Chem; 2007 May; 50(9):2259-63. PubMed ID: 17408248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topoisomerase inhibition by lucanthone, an adjuvant in radiation therapy.
    Bases RE; Mendez F
    Int J Radiat Oncol Biol Phys; 1997 Mar; 37(5):1133-7. PubMed ID: 9169823
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salvicine, a novel DNA topoisomerase II inhibitor, exerting its effects by trapping enzyme-DNA cleavage complexes.
    Meng LH; Zhang JS; Ding J
    Biochem Pharmacol; 2001 Sep; 62(6):733-41. PubMed ID: 11551518
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tirapazamine: a hypoxia-activated topoisomerase II poison.
    Peters KB; Brown JM
    Cancer Res; 2002 Sep; 62(18):5248-53. PubMed ID: 12234992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure-activity relationships in platinum-acridinylthiourea conjugates: effect of the thiourea nonleaving group on drug stability, nucleobase affinity, and in vitro cytotoxicity.
    Ackley MC; Barry CG; Mounce AM; Farmer MC; Springer BE; Day CS; Wright MW; Berners-Price SJ; Hess SM; Bierbach U
    J Biol Inorg Chem; 2004 Jun; 9(4):453-61. PubMed ID: 15067524
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unique base-step recognition by a platinum-acridinylthiourea conjugate leads to a DNA damage profile complementary to that of the anticancer drug cisplatin.
    Budiman ME; Alexander RW; Bierbach U
    Biochemistry; 2004 Jul; 43(26):8560-7. PubMed ID: 15222767
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, biological activity, and DNA-damage profile of platinum-threading intercalator conjugates designed to target adenine.
    Guddneppanavar R; Saluta G; Kucera GL; Bierbach U
    J Med Chem; 2006 Jun; 49(11):3204-14. PubMed ID: 16722638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The HSP90 and DNA topoisomerase VI inhibitor radicicol also inhibits human type II DNA topoisomerase.
    Gadelle D; Graille M; Forterre P
    Biochem Pharmacol; 2006 Nov; 72(10):1207-16. PubMed ID: 16959221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA topoisomerases as targets for the anticancer drug TAS-103: DNA interactions and topoisomerase catalytic inhibition.
    Fortune JM; Velea L; Graves DE; Utsugi T; Yamada Y; Osheroff N
    Biochemistry; 1999 Nov; 38(47):15580-6. PubMed ID: 10569942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships.
    Constantinou A; Mehta R; Runyan C; Rao K; Vaughan A; Moon R
    J Nat Prod; 1995 Feb; 58(2):217-25. PubMed ID: 7769390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro cytotoxicity and DNA damage production in Chinese hamster ovary cells and topoisomerase II inhibition by 2-[2'-(dimethylamino)ethyl]-1, 2-dihydro-3H-dibenz[de,h]isoquinoline-1,3-diones with substitutions at the 6 and 7 positions (azonafides).
    Mayr CA; Sami SM; Dorr RT
    Anticancer Drugs; 1997 Mar; 8(3):245-56. PubMed ID: 9095329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human DNA topoisomerase I: quantitative analysis of the effects of camptothecin analogs and the benzophenanthridine alkaloids nitidine and 6-ethoxydihydronitidine on DNA topoisomerase I-induced DNA strand breakage.
    Holden JA; Wall ME; Wani MC; Manikumar G
    Arch Biochem Biophys; 1999 Oct; 370(1):66-76. PubMed ID: 10496978
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bis(acridinylthiourea)platinum(II) complexes: synthesis, DNA affinity, and biological activity in glioblastoma cells.
    Augustus TM; Anderson J; Hess SM; Bierbach U
    Bioorg Med Chem Lett; 2003 Mar; 13(5):855-8. PubMed ID: 12617907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Study on the cytotoxic activity of platinum(II) complexes of (1R,2R)-N(1)-cyclopentyl-1,2-cyclohexanediamine with substituted malonate derivatives.
    Zhou Z; Chen F; Xu G; Gou S
    Bioorg Med Chem Lett; 2016 Jan; 26(2):322-327. PubMed ID: 26711148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dicationic bis(9-methylphenazine-1-carboxamides): relationships between biological activity and linker chain structure for a series of potent topoisomerase targeted anticancer drugs.
    Gamage SA; Spicer JA; Finlay GJ; Stewart AJ; Charlton P; Baguley BC; Denny WA
    J Med Chem; 2001 Apr; 44(9):1407-15. PubMed ID: 11311063
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of action of the dual topoisomerase-I and -II inhibitor TAS-103 and activity against (multi)drug resistant cells.
    Minderman H; Wrzosek C; Cao S; Utsugi T; Kobunai T; Yamada Y; Rustum YM
    Cancer Chemother Pharmacol; 2000; 45(1):78-84. PubMed ID: 10647506
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor agents. Part 230: C4'-esters of GL-331 as cytotoxic agents and DNA topoisomerase II inhibitors.
    Han S; Xiao Z; Bastow KF; Lee KH
    Bioorg Med Chem Lett; 2004 Jun; 14(11):2979-82. PubMed ID: 15125972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular Recognition and Repair of Monofunctional-Intercalative Platinum--DNA Adducts.
    Liu F; Suryadi J; Bierbach U
    Chem Res Toxicol; 2015 Nov; 28(11):2170-8. PubMed ID: 26457537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthetic inhibitors of DNA topoisomerase I and II.
    Katayama H; Kawada Y; Kaneko K; Oshiyama T; Takatsu N
    Chem Pharm Bull (Tokyo); 1999 Jan; 47(1):48-53. PubMed ID: 9987826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.